Diana Milojevic

1.9k citations
24 papers · 579 indexed · h-index 12

Diana Milojevic

23 papers receiving 568 citations

Peers

Diana Milojevic
Comparison fields: 5 of 58
  • Hematology 381
  • Speech and Hearing 216
  • Rheumatology 119
  • Immunology 156
  • Pediatrics, Perinatology and Child Health 65
Replace Y. Koopman-Keemink with:
Y. Koopman-Keemink Netherlands
C. Egla Rabinovich United States
Gabriella Giancane Italy
N. N. Kuzmina Russia
Dag Sørskaar Norway
Elżbieta Smolewska Poland
Polyxeni Pratsidou‐Gertsi Greece
Rubén Cuttica Argentina
Miroslav Harjaček Croatia
Е.I. Alexeeva Russia
Diana Milojevic relative to Y. Koopman-Keemink Netherlands Y. Koopman-Keemink's profile →
Citations per field
00.5×2.6×
Y. Koopman-Keemink · 1×
Citations per year

Countries citing papers authored by Diana Milojevic

Since Specialization
Citations

This map shows the geographic impact of Diana Milojevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Milojevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Milojevic more than expected).

Fields of papers citing papers by Diana Milojevic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Milojevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Milojevic. The network helps show where Diana Milojevic may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Diana Milojevic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diana Milojevic Line = papers co-authored together Diana Milojevic links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20238
3 20222
4 201919
5 20193
6 201716
7 201510
8 201516
9 201440
10 2012153
11 20125
12 20122
13 20121
14 20113
15 201038
16 200996
17 200961
18 200813
19 200213
20 20027

About Diana Milojevic

Diana Milojevic is a scholar working on Hematology, Speech and Hearing and Rheumatology, having authored 24 papers that have together received 579 indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (19 papers), Adolescent and Pediatric Healthcare (8 papers), Immune Cell Function and Interaction (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Inflammasome and immune disorders (4 papers), Kawasaki Disease and Coronary Complications (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Hematology (381 citations), Speech and Hearing (216 citations) and Rheumatology (119 citations). Diana Milojevic has collaborated with scholars based in United States, United Kingdom and Argentina. Frequent co-authors include Elizabeth Mellins, Khoa D. Nguyen, Claudia Macaubas, Jane L. Park, Norman T. Ilowite, Jolán E. Walter, Shirley Pang, Megan L. Curran, Emily von Scheven and Aimee O. Hersh. Their work appears in journals such as Annals of the Rheumatic Diseases, Nature Reviews Rheumatology and PROTEOMICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026